Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Cardiology · Atrial Fibrillation

The Biology of Hereditary AFib and Hidden Heart Conditions

At a Glance

Early-onset or familial AFib may be the first sign of an inherited heart-muscle or electrical condition, even when an echocardiogram looks normal. Genetic testing, cardiac MRI, ECG review, and family screening can clarify risk.

When AFib occurs in young people or runs in families, it is sometimes an isolated rhythm problem, but it can also involve complex genetics. Understanding the biology of hereditary AFib means looking at how your DNA instructs your heart to build its structure and manage its electrical signals [1][2].

Two Ways Your DNA Increases Risk

Genetic risk for AFib generally falls into two categories. Think of it like the difference between one loud siren and a crowd of people whispering [3].

  • Monogenic Risk (The Loud Siren): This is caused by a single, rare pathogenic variant in one gene that has a very strong effect. While rare in the general population, these variants are found in about 17% of people diagnosed with AFib before age 30 [4]. These cases are often “hereditary” because the single mutation is easily passed down through generations [5].
  • Polygenic Risk (The Whispering Crowd): Most people with AFib have this type. It involves hundreds or thousands of tiny genetic variations. Each one has a tiny effect on its own, but together they “nudge” your heart toward AFib [3][6]. This risk is often influenced more by lifestyle factors as you age [7].

AFib as a Possible Harbinger

For some, AFib can be a harbinger—an early warning sign—of an underlying heart condition that hasn’t fully shown itself yet [8]. This is why doctors may use early-onset AFib as a clue to check the rest of the heart’s health [1]. However, it is important to note that many people with familial AFib do not develop cardiomyopathy, and finding a gene can have incomplete penetrance.

A person might have a normal-looking heart on an initial ultrasound (echocardiogram), but their genetics may reveal they are at risk for structural or electrical diseases that could develop years later [9][8].

Channelopathy vs. Cardiomyopathy

Genetic heart conditions are broadly grouped into two “families.” Understanding which one is involved helps your care team decide how to monitor you [1].

1. Channelopathies (The “Wiring” Problems)

A channelopathy is a problem with the microscopic “tunnels” (ion channels) that move electricity in and out of your heart cells [10]. The heart structure may look normal, but the electrical timing is off.

  • Key Genes: SCN5A, KCNQ1, KCNH2 [11].
  • Risks: These genes can sometimes be linked to other rhythm issues, such as Long QT Syndrome or Brugada Syndrome [12]. Note that finding one of these genes does not automatically mean you have Brugada or Long QT; imaging and expert interpretation determine what a result means.

2. Cardiomyopathies (The “Foundation” Problems)

A cardiomyopathy is a disease of the heart muscle itself. The “foundation” or structure of the heart is weak, stiff, or unusually thick [13]. AFib is very common in these conditions because a struggling heart muscle often creates “electrical scars” that trigger the irregular rhythm [1][9].

  • Key Genes: TTN (Titin), LMNA (Lamin), MYH7 [2][14].
  • The TTN Connection: Pathogenic variants in the TTN gene are a common genetic find in early-onset AFib [2]. Some people with these variants have AFib for years before their heart muscle shows any signs of weakening (dilated cardiomyopathy) [15][16].
  • The LMNA Connection: Pathogenic variants in LMNA are particularly important to identify, as they can be associated with both AFib and future “wiring” problems (heart block) or ventricular arrhythmias [17][18].

Why Thorough Testing Matters

Because AFib can be an early sign of these conditions, a standard check-up is often just the beginning for young patients. Current guidelines suggest that for those diagnosed at age 45 or younger without obvious acquired risk factors, a more “precision” approach may be valuable [19]. This may include:

  1. Genetic Panels: A blood or saliva test to look for pathogenic variants [20].
  2. Cardiac MRI: This provides a much more detailed look than an ultrasound, searching for tiny amounts of fibrosis (scarring) [1].
  3. Family Screening: If a mutation is found, your siblings or children can be tested (cascade testing) [1][19].

Common questions in this guide

Does AFib in my family mean that I inherited a heart condition?
Not necessarily. AFib may result from one strong inherited gene change, many small genetic differences, or a mix of genetic and age-related factors. A family history raises the value of careful evaluation but does not prove that you have an inherited heart-muscle or electrical condition.
Why might someone with early-onset AFib need a cardiac MRI?
A cardiac MRI gives a more detailed view of the heart muscle than an echocardiogram and can detect scarring or early structural changes. It may help clinicians look for an underlying heart-muscle condition when AFib begins young or runs in the family.
What can genetic testing show in hereditary AFib?
A blood or saliva test can look for gene changes linked to abnormal heart electrical signals or heart-muscle disease. A clinically important result may guide your monitoring and help identify relatives who could benefit from testing, but it must be interpreted alongside ECG findings, imaging, and personal and family history.
What could a TTN or LMNA result mean if I have AFib?
Changes in TTN can occur in early-onset AFib and may sometimes come before signs of a weakened, enlarged heart. Changes in LMNA can be linked to AFib and later electrical problems such as heart block or dangerous ventricular rhythms, so clinicians may recommend ongoing heart checks. A gene finding does not predict exactly what will happen to one person.
What does a variant of uncertain significance mean on an AFib genetic test?
A variant of uncertain significance, or VUS, is a DNA change whose medical meaning is not yet clear. It should not by itself be used to diagnose an inherited heart condition or make major decisions about relatives. Its interpretation may change as researchers learn more.
If a pathogenic variant is found, should my relatives have heart screening?
If a clinically important pathogenic variant is identified, close relatives may be offered targeted cascade testing and heart screening. The plan may include more than an annual ECG, depending on the gene, symptoms, and family history. A genetics professional or cardiologist can coordinate the next steps.
What symptoms might suggest that AFib is linked to more than an irregular rhythm?
Severe shortness of breath, swelling in the legs, unexplained fainting, seizures, or a family history of early pacemaker or ICD placement should be shared with a clinician. These clues do not establish a diagnosis, but they may prompt evaluation for a heart-muscle or electrical disorder.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Hereditary atrial fibrillation.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my AFib look more like a 'monogenic' case (one major gene) or a 'polygenic' case (many small factors), and how does that change my care?
  2. 2.Since I have early-onset AFib, should I have a cardiac MRI to look for subtle scarring or signs of cardiomyopathy?
  3. 3.If we find a mutation in a gene like TTN or LMNA, how often will we need to check my heart's pumping function?
  4. 4.Are there specific 'red flags' on my ECG, like a long QT interval or first-degree heart block, that point toward a channelopathy?
  5. 5.How would a positive genetic test result for my relatives change their screening—do they need more than just an annual ECG?
  6. 6.What is the difference between a 'pathogenic' result and a 'variant of uncertain significance' (VUS) in my specific report?

References

References (20)
  1. 1

    The Therapeutic Impact of Genetic Evaluation in an Atrial Fibrillation Precision Medicine Clinic.

    Laws JL, Shabani M, Williams HL, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.03.28.25324544.

    PMID: 40196242
  2. 2

    Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes.

    Yoneda ZT, Anderson KC, Quintana JA, et al.

    JAMA cardiology 2021; (6(12)):1371-1379 doi:10.1001/jamacardio.2021.3370.

    PMID: 34495297
  3. 3

    Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National Biobank.

    Choi SH, Jurgens SJ, Weng LC, et al.

    Circulation research 2020; (126(2)):200-209 doi:10.1161/CIRCRESAHA.119.315686.

    PMID: 31691645
  4. 4

    Genetic testing in monogenic early-onset atrial fibrillation.

    Chalazan B, Freeth E, Mohajeri A, et al.

    European journal of human genetics : EJHG 2023; (31(7)):769-775 doi:10.1038/s41431-023-01383-z.

    PMID: 37217627
  5. 5

    Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation: A Population-Based Family Cohort Study.

    Chang SH, Kuo CF, Chou IJ, et al.

    JAMA cardiology 2017; (2(8)):863-870 doi:10.1001/jamacardio.2017.1855.

    PMID: 28678986
  6. 6

    Meta-analysis of genome-wide associations and polygenic risk prediction for atrial fibrillation in more than 180,000 cases.

    Roselli C, Surakka I, Olesen MS, et al.

    Nature genetics 2025; (57(3)):539-547 doi:10.1038/s41588-024-02072-3.

    PMID: 40050429
  7. 7

    Age-Dependent Contributions of Rare and Common Genetic Variation in Atrial Fibrillation.

    Chen Z, Aziz PF, Greenland P, et al.

    Circulation. Genomic and precision medicine 2025; (18(5)):e004958 doi:10.1161/CIRCGEN.124.004958.

    PMID: 40931808
  8. 8

    Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation.

    Wijdeveld LFJM, Ajufo E, Challa SP, et al.

    JAMA cardiology 2025; (10(6)):564-573 doi:10.1001/jamacardio.2025.0460.

    PMID: 40305039
  9. 9

    Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes.

    Yoneda ZT, Anderson KC, Ye F, et al.

    JAMA cardiology 2022; (7(7)):733-741 doi:10.1001/jamacardio.2022.0810.

    PMID: 35544069
  10. 10

    IKs Gain- and Loss-of-Function in Early-Onset Lone Atrial Fibrillation.

    Steffensen AB, Refsgaard L, Andersen MN, et al.

    Journal of cardiovascular electrophysiology 2015; (26(7)):715-23 doi:10.1111/jce.12666.

    PMID: 25786344
  11. 11

    Functional Characterization of Rare Variants Implicated in Susceptibility to Lone Atrial Fibrillation.

    Hayashi K, Konno T, Tada H, et al.

    Circulation. Arrhythmia and electrophysiology 2015; (8(5)):1095-104 doi:10.1161/CIRCEP.114.002519.

    PMID: 26129877
  12. 12

    Clinical presentation and genetic characterization of early-onset atrial fibrillation in patients affected by long QT syndrome: A single-center experience.

    Sarubbi B, Ciriello GD, Barretta F, et al.

    Journal of cardiovascular electrophysiology 2024; (35(10)):1941-1951 doi:10.1111/jce.16384.

    PMID: 39082327
  13. 13

    Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk.

    Choi SH, Jurgens SJ, Xiao L, et al.

    Nature genetics 2025; (57(3)):548-562 doi:10.1038/s41588-025-02074-9.

    PMID: 40050430
  14. 14

    Population-Level Prevalence of Rare Variants Associated With Atrial Fibrillation and its Impact on Patient Outcomes.

    Kandola MS, Kulm S, Kim LK, et al.

    JACC. Clinical electrophysiology 2023; (9(7 Pt 2)):1137-1146 doi:10.1016/j.jacep.2022.11.022.

    PMID: 36669898
  15. 15

    Enrichment of loss-of-function and copy number variants in ventricular cardiomyopathy genes in 'lone' atrial fibrillation.

    Lazarte J, Laksman ZW, Wang J, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2021; (23(6)):844-850 doi:10.1093/europace/euaa421.

    PMID: 33682005
  16. 16

    Clinical Characteristics and Outcomes in Patients With Atrial Fibrillation and Pathogenic TTN Variants.

    Virk ZM, El-Harasis MA, Yoneda ZT, et al.

    JACC. Clinical electrophysiology 2024; (10(11)):2445-2457 doi:10.1016/j.jacep.2024.07.029.

    PMID: 39453294
  17. 17

    Effect of Occurrence of Lamin A/C (LMNA) Genetic Variants in a Cohort of 101 Consecutive Apparent "Lone AF" Patients: Results and Insights.

    Pessente GD, Sacilotto L, Calil ZO, et al.

    Frontiers in cardiovascular medicine 2022; (9()):823717 doi:10.3389/fcvm.2022.823717.

    PMID: 35449878
  18. 18

    Atrial Fibrillation in Genotyped Dilated Cardiomyopathy: Epidemiology, Risk Factors, and Outcomes: Insights From the SHaRe Registry.

    Balakrishnan ID, Heymans ABM, Claggett B, et al.

    Circulation. Heart failure 2026; e014322 doi:10.1161/CIRCHEARTFAILURE.125.014322.

    PMID: 42717878
  19. 19

    Genetic testing in early-onset atrial fibrillation.

    Kany S, Jurgens SJ, Rämö JT, et al.

    European heart journal 2024; (45(34)):3111-3123 doi:10.1093/eurheartj/ehae298.

    PMID: 39028637
  20. 20

    Genetically based atrial fibrillation: Current considerations for diagnosis and management.

    Pensa AV, Baman JR, Puckelwartz MJ, Wilcox JE

    Journal of cardiovascular electrophysiology 2022; (33(8)):1944-1953 doi:10.1111/jce.15446.

    PMID: 35262243

This page is for informational purposes only and does not constitute medical advice. A cardiologist or genetics professional can interpret your AFib history and genetic results and recommend appropriate screening.